𝔖 Bobbio Scriptorium
✦   LIBER   ✦

499 RHO-kinase inhibitor suppresses tumor growth and intrahepatic metastases of hepatocellular carcinoma—In vitro and in vivo study

✍ Scribed by Feng Xue; Terumi Takahara; Kazunobu Nonome; Yutaka Yata; Eiji Shinno; Akiharu Watanabe

Book ID
119530405
Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
147 KB
Volume
38
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Suppression of growth of hepatocellular
Suppression of growth of hepatocellular carcinoma by sodium butyrate in vitro and in vivo
✍ Hidenao Yamamoto; Jiro Fujimoto; Eizo Okamoto; Jun-ichi Furuyama; Taiki Tamaoki; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 146 KB 👁 1 views

Treatment of HuH-7 human hepatocellular carcinoma (HCC) cells with 1-10 mM sodium butyrate (SB) resulted in growth inhibition in a dose-dependent manner. At 3 mM and higher concentrations, SB caused nuclear fragmentation and DNA ladder formation characteristic of apoptosis. In the treated cells, the

Targeted disruption of Nemo-like kinase
Targeted disruption of Nemo-like kinase inhibits tumor cell growth by simultaneous suppression of cyclin D1 and CDK2 in human hepatocellular carcinoma
✍ Kwang Hwa Jung; Jeong Kyu Kim; Ji Heon Noh; Jung Woo Eun; Hyun Jin Bae; Hong Jia 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 504 KB

## Abstract The Wnt/β‐catenin signaling pathway regulates various aspects of development and plays important role in human carcinogenesis. Nemo‐like kinase (NLK), which is mediator of Wnt/β‐catenin signaling pathway, phosphorylates T‐cell factor/lymphoid enhancer factor (TCF/LEF) factor and inhibit